VBIV - PRICE - VBI Vaccines Inc.

The VBI Vaccines Inc. (VBIV) price chart on the GURU.Markets platform reflects the dynamics of a biotech firm whose operations are constrained by strict FDA oversight and the complexity of establishing vaccine production capacities. A patent-protected portfolio of Hepatitis B drugs serves as a steady cash generator. However, the current metric stands at , driven by an acute shortage of funds, the search for new asset owners, and a profound restructuring of the business model.

The integration of strict ESG standards into the vaccine production of VBI Vaccines Inc. (VBIV) enhances industrial safety and the investment attractiveness of its assets. The linear price action allows a strategic buyer to calculate market capitalization and determine a fair acquisition premium, separating the business's fundamental value from short-term volatility through a volume-weighted average price analysis for the period.